GO:0016874 | ligase activity | 8.57% (6/70) | 4.11 | 1e-06 | 0.000328 |
GO:0005488 | binding | 31.43% (22/70) | 1.53 | 3e-06 | 0.000356 |
GO:0003674 | molecular_function | 41.43% (29/70) | 1.16 | 7e-06 | 0.000627 |
GO:0006418 | tRNA aminoacylation for protein translation | 5.71% (4/70) | 4.85 | 1.1e-05 | 0.000696 |
GO:0016875 | ligase activity, forming carbon-oxygen bonds | 5.71% (4/70) | 4.58 | 2.2e-05 | 0.000732 |
GO:0004812 | aminoacyl-tRNA ligase activity | 5.71% (4/70) | 4.58 | 2.2e-05 | 0.000732 |
GO:0034660 | ncRNA metabolic process | 7.14% (5/70) | 3.83 | 2.7e-05 | 0.000774 |
GO:0043039 | tRNA aminoacylation | 5.71% (4/70) | 4.62 | 2e-05 | 0.000871 |
GO:0043038 | amino acid activation | 5.71% (4/70) | 4.62 | 2e-05 | 0.000871 |
GO:0016070 | RNA metabolic process | 10.0% (7/70) | 2.85 | 5.1e-05 | 0.001326 |
GO:0043167 | ion binding | 18.57% (13/70) | 1.7 | 0.000147 | 0.002031 |
GO:0097367 | carbohydrate derivative binding | 14.29% (10/70) | 2.04 | 0.000145 | 0.002108 |
GO:0140101 | catalytic activity, acting on a tRNA | 5.71% (4/70) | 4.08 | 9e-05 | 0.002144 |
GO:0032553 | ribonucleotide binding | 14.29% (10/70) | 2.04 | 0.000143 | 0.002198 |
GO:0036094 | small molecule binding | 15.71% (11/70) | 1.91 | 0.000139 | 0.002282 |
GO:0017076 | purine nucleotide binding | 14.29% (10/70) | 2.05 | 0.000136 | 0.002377 |
GO:0032555 | purine ribonucleotide binding | 14.29% (10/70) | 2.07 | 0.00012 | 0.002416 |
GO:0043168 | anion binding | 15.71% (11/70) | 1.92 | 0.000132 | 0.002465 |
GO:0006399 | tRNA metabolic process | 5.71% (4/70) | 3.8 | 0.000193 | 0.002533 |
GO:0035639 | purine ribonucleoside triphosphate binding | 14.29% (10/70) | 2.08 | 0.000116 | 0.002535 |
GO:0008144 | drug binding | 12.86% (9/70) | 2.09 | 0.00025 | 0.003121 |
GO:0006139 | nucleobase-containing compound metabolic process | 11.43% (8/70) | 2.23 | 0.000293 | 0.003486 |
GO:1901265 | nucleoside phosphate binding | 14.29% (10/70) | 1.86 | 0.000396 | 0.004319 |
GO:0000166 | nucleotide binding | 14.29% (10/70) | 1.86 | 0.000396 | 0.004319 |
GO:0097159 | organic cyclic compound binding | 18.57% (13/70) | 1.47 | 0.000699 | 0.005387 |
GO:1901363 | heterocyclic compound binding | 18.57% (13/70) | 1.47 | 0.000699 | 0.005387 |
GO:0006725 | cellular aromatic compound metabolic process | 11.43% (8/70) | 2.08 | 0.000591 | 0.005529 |
GO:0090304 | nucleic acid metabolic process | 10.0% (7/70) | 2.26 | 0.000617 | 0.00557 |
GO:1901360 | organic cyclic compound metabolic process | 11.43% (8/70) | 2.04 | 0.000681 | 0.005579 |
GO:0030554 | adenyl nucleotide binding | 11.43% (8/70) | 2.0 | 0.000819 | 0.005649 |
GO:0006520 | cellular amino acid metabolic process | 5.71% (4/70) | 3.34 | 0.000648 | 0.005658 |
GO:0015035 | protein disulfide oxidoreductase activity | 2.86% (2/70) | 5.75 | 0.000583 | 0.005661 |
GO:0015036 | disulfide oxidoreductase activity | 2.86% (2/70) | 5.75 | 0.000583 | 0.005661 |
GO:0032559 | adenyl ribonucleotide binding | 11.43% (8/70) | 2.01 | 0.000807 | 0.005715 |
GO:0140098 | catalytic activity, acting on RNA | 5.71% (4/70) | 3.33 | 0.000677 | 0.005722 |
GO:0046483 | heterocycle metabolic process | 11.43% (8/70) | 2.09 | 0.000554 | 0.005805 |
GO:0005524 | ATP binding | 11.43% (8/70) | 2.01 | 0.000783 | 0.005861 |
GO:0034641 | cellular nitrogen compound metabolic process | 12.86% (9/70) | 1.85 | 0.000806 | 0.005863 |
GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors | 2.86% (2/70) | 5.05 | 0.001601 | 0.010485 |
GO:0044237 | cellular metabolic process | 17.14% (12/70) | 1.41 | 0.001591 | 0.010691 |
GO:0044281 | small molecule metabolic process | 7.14% (5/70) | 2.51 | 0.001832 | 0.010906 |
GO:0019752 | carboxylic acid metabolic process | 5.71% (4/70) | 2.96 | 0.001751 | 0.010921 |
GO:0043436 | oxoacid metabolic process | 5.71% (4/70) | 2.96 | 0.001751 | 0.010921 |
GO:0006082 | organic acid metabolic process | 5.71% (4/70) | 2.94 | 0.001809 | 0.011024 |
GO:0006807 | nitrogen compound metabolic process | 15.71% (11/70) | 1.41 | 0.00254 | 0.014465 |
GO:0043170 | macromolecule metabolic process | 14.29% (10/70) | 1.51 | 0.002486 | 0.014475 |
GO:0009055 | electron transfer activity | 2.86% (2/70) | 4.58 | 0.003093 | 0.017244 |
GO:1901070 | guanosine-containing compound biosynthetic process | 1.43% (1/70) | 7.75 | 0.004639 | 0.01899 |
GO:1901659 | glycosyl compound biosynthetic process | 1.43% (1/70) | 7.75 | 0.004639 | 0.01899 |
GO:1901068 | guanosine-containing compound metabolic process | 1.43% (1/70) | 7.75 | 0.004639 | 0.01899 |
GO:0042455 | ribonucleoside biosynthetic process | 1.43% (1/70) | 7.75 | 0.004639 | 0.01899 |
GO:0046129 | purine ribonucleoside biosynthetic process | 1.43% (1/70) | 7.75 | 0.004639 | 0.01899 |
GO:0046128 | purine ribonucleoside metabolic process | 1.43% (1/70) | 7.75 | 0.004639 | 0.01899 |
GO:0030688 | preribosome, small subunit precursor | 1.43% (1/70) | 7.75 | 0.004639 | 0.01899 |
GO:0006420 | arginyl-tRNA aminoacylation | 1.43% (1/70) | 7.75 | 0.004639 | 0.01899 |
GO:0003922 | GMP synthase (glutamine-hydrolyzing) activity | 1.43% (1/70) | 7.75 | 0.004639 | 0.01899 |
GO:0006177 | GMP biosynthetic process | 1.43% (1/70) | 7.75 | 0.004639 | 0.01899 |
GO:0004814 | arginine-tRNA ligase activity | 1.43% (1/70) | 7.75 | 0.004639 | 0.01899 |
GO:0009163 | nucleoside biosynthetic process | 1.43% (1/70) | 7.75 | 0.004639 | 0.01899 |
GO:0042278 | purine nucleoside metabolic process | 1.43% (1/70) | 7.75 | 0.004639 | 0.01899 |
GO:0042451 | purine nucleoside biosynthetic process | 1.43% (1/70) | 7.75 | 0.004639 | 0.01899 |
GO:0046037 | GMP metabolic process | 1.43% (1/70) | 7.75 | 0.004639 | 0.01899 |
GO:0042274 | ribosomal small subunit biogenesis | 1.43% (1/70) | 7.75 | 0.004639 | 0.01899 |
GO:0043229 | intracellular organelle | 7.14% (5/70) | 2.14 | 0.005562 | 0.022079 |
GO:0043226 | organelle | 7.14% (5/70) | 2.14 | 0.005562 | 0.022079 |
GO:0003824 | catalytic activity | 20.0% (14/70) | 1.11 | 0.004366 | 0.023829 |
GO:0009987 | cellular process | 20.0% (14/70) | 1.05 | 0.006217 | 0.024311 |
GO:1901564 | organonitrogen compound metabolic process | 11.43% (8/70) | 1.52 | 0.006432 | 0.02478 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 1.43% (1/70) | 6.75 | 0.009256 | 0.0282 |
GO:0009156 | ribonucleoside monophosphate biosynthetic process | 1.43% (1/70) | 6.75 | 0.009256 | 0.0282 |
GO:0000959 | mitochondrial RNA metabolic process | 1.43% (1/70) | 6.75 | 0.009256 | 0.0282 |
GO:0034404 | nucleobase-containing small molecule biosynthetic process | 1.43% (1/70) | 6.75 | 0.009256 | 0.0282 |
GO:0009161 | ribonucleoside monophosphate metabolic process | 1.43% (1/70) | 6.75 | 0.009256 | 0.0282 |
GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA | 1.43% (1/70) | 6.75 | 0.009256 | 0.0282 |
GO:0110156 | methylguanosine-cap decapping | 1.43% (1/70) | 6.75 | 0.009256 | 0.0282 |
GO:0006402 | mRNA catabolic process | 1.43% (1/70) | 6.75 | 0.009256 | 0.0282 |
GO:0043461 | proton-transporting ATP synthase complex assembly | 1.43% (1/70) | 6.75 | 0.009256 | 0.0282 |
GO:0009123 | nucleoside monophosphate metabolic process | 1.43% (1/70) | 6.75 | 0.009256 | 0.0282 |
GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 1.43% (1/70) | 6.75 | 0.009256 | 0.0282 |
GO:0009167 | purine ribonucleoside monophosphate metabolic process | 1.43% (1/70) | 6.75 | 0.009256 | 0.0282 |
GO:0009119 | ribonucleoside metabolic process | 1.43% (1/70) | 6.75 | 0.009256 | 0.0282 |
GO:0009124 | nucleoside monophosphate biosynthetic process | 1.43% (1/70) | 6.75 | 0.009256 | 0.0282 |
GO:0009126 | purine nucleoside monophosphate metabolic process | 1.43% (1/70) | 6.75 | 0.009256 | 0.0282 |
GO:0009127 | purine nucleoside monophosphate biosynthetic process | 1.43% (1/70) | 6.75 | 0.009256 | 0.0282 |
GO:0110154 | RNA decapping | 1.43% (1/70) | 6.75 | 0.009256 | 0.0282 |
GO:0044238 | primary metabolic process | 15.71% (11/70) | 1.17 | 0.008669 | 0.032916 |
GO:0008152 | metabolic process | 18.57% (13/70) | 0.99 | 0.011811 | 0.035569 |
GO:1901137 | carbohydrate derivative biosynthetic process | 2.86% (2/70) | 3.58 | 0.012071 | 0.035939 |
GO:0043227 | membrane-bounded organelle | 4.29% (3/70) | 2.57 | 0.014139 | 0.039831 |
GO:0043231 | intracellular membrane-bounded organelle | 4.29% (3/70) | 2.57 | 0.014139 | 0.039831 |
GO:0006401 | RNA catabolic process | 1.43% (1/70) | 6.17 | 0.013853 | 0.039884 |
GO:0010629 | negative regulation of gene expression | 1.43% (1/70) | 6.17 | 0.013853 | 0.039884 |
GO:0071704 | organic substance metabolic process | 15.71% (11/70) | 1.08 | 0.013737 | 0.04044 |